Hanxiang Liu

机构：Xuzhou Medical College, Sichuan University, Fudan University, West China Second University Hospital of Sichuan University · ORCID：0000-0003-3438-8333

发表论文 38 篇 · 总被引 661 次 · h-index 13

代表论文

• Value of [68Ga]Ga-FAPI-04 imaging in the diagnosis of renal fibrosis (2021 · European Journal of Nuclear Medicine and Molecular Imaging · 被引 124)
• The potential utility of [68 Ga]Ga-DOTA-FAPI-04 as a novel broad-spectrum oncological and non-oncological imaging agent—comparison with [18F]FDG (2021 · European Journal of Nuclear Medicine and Molecular Imaging · 被引 100)
• Development of the psychosomatic symptom scale (PSSS) and assessment of its reliability and validity in general hospital patients in China (2020 · General Hospital Psychiatry · 被引 49)
• Lutetium177-Labeled DOTA-Ibandronate: A Novel Radiopharmaceutical for Targeted Treatment of Bone Metastases (2023 · Molecular Pharmaceutics · 被引 48)
• Safety and Efficacy of 68Ga- or 177Lu-Labeled DOTA-IBA as a Novel Theranostic Radiopharmaceutical for Bone Metastases (2023 · Clinical Nuclear Medicine · 被引 43)
• Preparation, biological characterization and preliminary human imaging studies of 68Ga-DOTA-IBA (2022 · Frontiers in Oncology · 被引 41)